Citadel Advisors
IMNM icon

Citadel Advisors’s Immunome IMNM Stock Holding History

Citadel Advisors’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.75M Sell
80,197
-1,660,508
-95% -$37M ﹤0.01% 6364
2025
Q4 		$37.4M Buy
1,740,705
+899,567
+107% +$15.8M 0.01% 1694
2025
Q3 		$9.85M Buy
+841,138
New +$8.37M ﹤0.01% 3298
2025
Q2 		– Sell
-340,103
Closed -$2.79M – 13720
2025
Q1 		$2.29M Buy
340,103
+244,237
+255% +$2.34M ﹤0.01% 5283
2024
Q4 		$1.02M Buy
+95,866
New +$1.16M ﹤0.01% 6968
2024
Q3 		– Sell
-4,167
Closed -$59.2K – 14697
2024
Q2 		$50.4K Buy
+4,167
New +$65.2K ﹤0.01% 11750
2024
Q1 		– Sell
-2,630
Closed -$53.4K – 14993
2023
Q4 		$28.1K Sell
2,630
-4,863
-65% -$40.4K ﹤0.01% 12318
2023
Q3 		$62.6K Buy
7,493
+6,394
+582% +$47K ﹤0.01% 11469
2023
Q2 		$8.69K Sell
1,099
-1,841
-63% -$10.1K ﹤0.01% 13302
2023
Q1 		$14.7K Buy
+2,940
New +$14.4K ﹤0.01% 13290
2022
Q3 		– Sell
-13,159
Closed -$61.7K – 13076
2022
Q2 		$42K Buy
+13,159
New +$47.9K ﹤0.01% 12034
2022
Q1 		– Sell
-21,216
Closed -$159K – 14058
2021
Q4 		$275K Buy
21,216
+2,868
+16% +$51.1K ﹤0.01% 11098
2021
Q3 		$447K Buy
+18,348
New +$320K ﹤0.01% 10152

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Citadel Advisors's IMNM Position: Q1 2026 in Review

Citadel Advisors reduced its Immunome (IMNM) stake by 95% in Q1 2026, selling an estimated $37M and leaving 80,197 shares worth $1.75M. The position accounts for ﹤0.01% of the portfolio, ranked #6364.

Citadel Advisors first reported a position in IMNM in Q3 2021 and has held it in 13 quarters since. The position peaked at $37.4M in Q4 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Citadel Advisors held 80,197 shares of Immunome worth $1.75M as of Q1 2026.
  • Citadel Advisors sold 1,660,508 Immunome shares in Q1 2026, an estimated $37M.
  • Immunome made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6364 holding.
  • Citadel Advisors first reported a position in Immunome in Q3 2021 and has held it in 13 quarters since.
  • Citadel Advisors's Immunome position peaked at $37.4M in Q4 2025.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.